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Abstract
Antithrombotic effect of the copper-aspirin complex (dimeric copper(II) bis(o-acetoxybenzoate)
was evaluated in the model of venous thrombosis; its effects on platelet-neutrophil adhesion were
investigated by use of rosette assay. The results showed that the intragastrically administered copper-
aspirin complex (5, 7, and 10 mg kg"l) dose-dependently lowered the wet and dry thrombus weight; it
significantly decreased the binding of araehidonic acid-activated platelets to neutrophils with an IC50
value of 41.5 9tool L". The results suggested that copper aspirinate inhibited platelet-neutrophil adhesion
and resulted in a more potent antithmmbotie activity.
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INTRODUCrlON
Neutrophils and platelets, but not platelets alone, are closely associated with thromboembolic
disorders [1]. The copper-aspirin complex was investigated to show lower gastrointestinal side effects [2]
and more potent antiplatelet activity through elevating 6-keto-prostaglandin F level while decreasing
thromboan B2 generation in plasma[3]. The aim of this experiment is to further investigate the effect of
copper aspifinate on platelet-neutrophil adhesion and its influence on ligated venous thrombosis.
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Fig. Structure ofthe copper-aspirin complex
MATERIALS METHODS
Animals
Male Sprague Dawley rats weighing 200- 250 g were used in this study in accordance with the
ethics committee of our Laboratories (Certificate 9805, the Administrative Commission of Medical
Experimental Animals of Yunnan Public Health Bureau).
Chemicals andDrugs
Copper aspirinate (Cu 14.99%, C 51.21%, and H 3.32%; purity > 98%) was synthesized by
Kunming Institute of Precious Metals. It was dissolved in 0.9 % saline (pH 6.5). Crystalline aspirin was
dissolved in 1% NazCO3 before use. Arachidonic acid (AA) was from Sigma Chemical Co. It was
dissolved in 100 mmol L
"1 Na2CO3 before use.
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Preparation ofligatedvenous thrombosis
SD rats were divided into 5 groups with 10 rats each. A: 0.9 % saline as vehicle group; B: aspirin
20.0 mg / kg as reference; and C E: 5, 7, and 10 mg / kg copper-aspirin complex treated groups. All the
above substances were administered intragastrically h before experiment. The method of Chert
Changxun et al[4] was used to produce the model of venous thrombosis. Briefly, the rats were
anesthetized by ip 30.0 mg / kg sodium pentobarbital. Then a midline incision of the abdomen was made
and the inferior vena cava was isolated and ligated below the left renal vein level. The abdomen was then
closed. One hour later, the abdomen was reopened. The thrombus in the inferior vena cava was collected
into a glass dish for measurement of wet weight. It was then placed in a drying oven at 60C for 20 h
before measuring the dry weight. Significance was analyzed by t test.
Preparation ofplatelets
Blood sample from rat carotid artery was collected into plastic tubes, anticoagulated with 2.7
% EDTA. This sample was spun for 10 min at 180 Ixg to obtain platelet-rich plasma (PRP). PRP
was fluter spun to pellet platelets at 1000 tg for 10 rain. Platelet pellets were washed three times
and resusroended in phosphate buffer solution (PBS, containing 1.0 % bovine serum albumin and 1.4
mmol L EDNA). CII viability by Typan blue exclusion was above 95 % and cell counter was
adjusted to 10 cell L.
Preparation ofneutrophils
Neutrophils were isolated from the resulting blood by dextran sedimentation and followed by
Ficoll-Hypaque (special gravity 1.077) and hypotonic lysis of erythrocytes. The cell pellet was
resuspended in an erythrocyte lysis buffer composed of 155 mmol L
q NH4CI, 2.96 mmol L
"l KHCO3, and
3.72 mmol L EDTA. The tube was gently inverted and after 5 rain the suasion was centrifuged at
350 tg for 10 rain, and the cell pellet was washed in PBS lacking calcium; then resuded in Hanks’
solution (containing mmol L
q CaCI2 or 5 mmol L
q EGTA in vehicle, reflecting the situation with or
without external calcium). Cells were adjusted to a count of 2x106 cell mLq. Cells prepared in this
manner contained 98 % neutrophils and were 96% viable.
Rosette assay
The method of Hamburger et al [5] was modified. Briefly, 50 tL aliquots of platelet suspension
mmol L) for 15 min at room were placed in microtiter wells and exposed to arachidonic acid (0.
temperature without stirring. Fifty gL of 0.9 % saline or drug solution was added and incubated for 15
mm at 37C. Then 100 xL of neutrophils was added to the platelet suspension and incubated for 30 min at
4C under rocking condition. One hundred neutrophils were scored for the presence (two or more
platelets per neutrophil) or absence (zero or one platelet per neutrophil) of platelets. Neutrophils bearing
two or more platelets were thus defined as rosettes. For each assay, done in triplicate, the rosetting score
was assessed by two different observers.
RESULTS AND DISCUSSION
In vehicle group, the wet and dry thrombus weight were 9.9 +/- 1.8 and 4.1 +/- 0.5 mg, respectively.
Intragastri,c, administratiOno 5o, f,_ aspirin,,20 mg / kg significantly reduced the wet and dry thrombus weight to
2.2 _
1.3 and 1.0 +/- mg ( P < 0.01 vs vehicle). The copper-aspirin complex administered
intragastrically at 5,,7, and 10 mg / kg markedly decreased the wet thrombus weight to 4.9 +/- 2.1", 2.7 +/-
1.9"*, and 2.3 +/- 1.0" mg, and suppressed the dry thrombus weight to 1.5 +/- 0.6", 1.2 +/- 0.7", and 0.8 +/-
0.6"* mg P < 0.01 vs vehicle), respectively. (Table I)
Table I. Effect of the copper-aspirin complex administered intragastrically on rat venous
thrombosis ( n lO,x +/- s, P< 0.01 vs saline)
Drug Dose Thrombus weight (mg)
(mg / kg) Wet Dry
0.9 % saline 9.9 +/- 1.8 4.1 +/- 0.5
Copper 5 4.9 +/- 2.1"" 1.5 +/- 0.6**
Copper-
asplnn
complex
_0.7"* 7 2.7+/-19" 1.2/
10 2.3 +/- 1.0" 0.8 +/-
Aspirin 20 2.2 +/- 3"" 1.0 +/-
Our previous research indicated that the copper aspirin complex had a more potent antiplatelet
activity [3]. But all this work was focused on platelets alone, not involved in neutrophils.
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Platelet-neutrophil adhesion may play key factors in thromboembolic processes and adhesion of
these two kinds of blood cells is involved in the process of thrombomodulation [1]. Activation of platelets
increases neutrophil adhesion to foreign surfaces, neutrophile aggregation, lysosomal enzyme release, etc.
Platelet-derived products are able to promote neutrophil chemotaxsis, enzyme release, and phagocytosis
and to inhibit oxidative burst [6]. On the other hand, neutrophil-derived products can enhance platelet
aggregation, semtonin release and cytoplasmic Ca-+ movement [7]. It is necessary, therefore, to study an
antithrombotic drug based on its influence on multiple cellular interactions.
In venous thrombosis, the copper-aspirin complex showed a dose-dependently inhibition, seven
mg kg
1 of copper aspirinate obtained nearly equal antithrombotic effect to 20 mg kg
1 of its parent
compoundmaspirin. Obviously, copper aspir;mate exhibited a more potent antithrombosis.
The percentage of rosettes in vehicle was 71.8 or 11.6 % in a condition of external mmol L
"1
CaC12 or 5 mmol L EGTA. Copper aspirinate and aspirin significantly decreased the binding of platelets
to neutrophils with mmol L" external Ca2+, giving IC50 values 41.5 and 51.4 tmol L, respectively
(Table II).
Table H. Effect ofthe copper-aspirin complex on the bin.d.ing of arachidonic acid-stimulated
platelets to neutrophils in.rats (n 9,.x +/- S, P< 0.01 ,s 0.9 % saline)
Drug / trnol L
"1 Adhesion (%)
Copper-aspirin complex Aspirin
0 71.9 +/- 5.2 71.9 +/- 5.2
15 58.9 +/- 5.1 66.9 +/- 3.9
30 40.7 +/- 3.7 46.0 +/- 4.7
60 30.1 +/- 2.3 29.0 +/- 1.2
120 24.0 +/- 2.1 25.2 +/- 2.4
Thrombus formation is mediated by the platelet-neutrophil interactions including cell binding and
platelet aggregation. In vehicle (0.9 % saline) containing external mmol L
I CaCI2 or 5 mmol L EGTA,
the percentage of rosettes induced by AA was 71.8 or 11.2 %, demonstrating a calcium dependent
relationship between platelet-neutrophil adhesion. Both the copper-aspirin complex and aspirin showed
significant inhibition on rosetting between AA-activated platelets and neutrophils, and was more active
than aspirin based on the IC50 value. It is suggested that the copper-aspirin complex showed more potent
antithrombotic activity than aspirin due to its higher activity on platelet-neutrophil adhesion.
In conclusion, the copper-aspirin complex may be more potential in treating thromboembolic
diseases because of its lower gastrointestinal side effects.
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